Low miR‐19b‐1‐5p Expression Is Related to Aspirin Resistance and Major Adverse Cardio‐ Cerebrovascular Events in Patients With Acute Coronary Syndrome

Low miR‐19b‐1‐5p Expression Is Related to Aspirin Resistance and Major Adverse Cardio‐ Cerebrovascular Events in Patients With Acute Coronary Syndrome

Background Because of a nonresponse to aspirin (aspirin resistance), patients with acute coronary syndrome (ACS) are at increased risk of developing recurrent event. The in vitro platelet function tests have potential limitations, making them unsuitable for the detection of aspirin resistance. We in...

Full description

Bibliographic Details
Main Authors: Sandeep Singh, Maurice W. J. de Ronde, Esther E. Creemers, Ingeborg Van der Made, Roelien Meijering, Mark Y. Chan, Sock Hwee Tan, Chee Tang Chin, A. Mark Richards, Richard W. Troughton, Alan Yean Yip Fong, Bryan P. Yan, Sara‐Joan Pinto‐Sietsma
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
aspirin resistance
biomarkers
coronary artery disease
microRNAs
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.017120

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.017120

Similar Items